Loading TECH detail
Loading ticker data...
Loading TECH detail
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014.
Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Chart data unavailable
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Somnigroup International Inc. (NYSE: SGI). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Somnigroup International stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Packaging Corporation of America (NYSE: PKG). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Packaging Corporation of America stock on March 17th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Tractor Supply Company (NASDAQ: TSCO). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Tractor Supply stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of
CMB.TECH is now a highly leveraged play on freight rates, with over 80% spot exposure post-merger and tripled operating scale. Reported EPS is distorted by one-off Golden Ocean deal costs; normalized earnings and EBITDA provide a clearer view of CMBT's true earnings power. CMBT's valuation and investment case hinge on freight rate sensitivity, with current market cap implying mid-to-high cycle TCE rates ($35k–45k/day).
CMB.TECH ANNOUNCES FINAL YEAR RESULTS ANTWERP, Belgium, 31 March 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” of “the company” (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its final financial results today for the full year ended 31 December 2025. HIGHLIGHTS 2025 Financial highlights: Profit of USD 89.1 million in Q4 2025 bringing full year profit to USD 139.1 million No major changes compared to the preliminary figures published on 26/2/26 Total contract backlog increased to USD 3.05 billion Fleet highlights: CMB.TECH focused on its fleet rejuvenation with 17 newbuild deliveries 8 Newcastlemaxes 1 Crude oil tanker 1 Chemical tanker 5 CTVs 2 CSOVs Further fleet expansion with 9 vessels ordered (6 chemical tankers, 2 CTVs and 1 MP-ASV) Sale of 12 older vessels (5 VLCCs, 2 Suezmaxes, 2 Capesizes, 2 Panamaxes and 1 CTV) Fortescue and CMB.TECH signed agreement for ammonia-powered Newcastlemax CMB.TECH and MOL signed landmark agreement for nine ammonia-powered vessels Corporate highlights: On March 4 2025, CMB.TECH announced that it entered into a share purchase agreement with Hemen Holding Limited for the acquisition of 81,363,730 shares in Golden Ocean Group Limited.
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced layered amplification (seqLA™) technology enabling improved detection of low-abundance and challenging targets.
Shares of Bio-Techne Corp (NASDAQ: TECH - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the fifteen ratings firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has given a strong buy
TECH expands via acquisitions and global growth, but biotech funding softness, U.S. academic spending pressure and competition cloud near-term outlook.
Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The position was previously 2.3% of the fund's AUM as of the prior quarter.
Representative April McClain Delaney (Democratic-Maryland) recently sold shares of CDW Corporation (NASDAQ: CDW). In a filing disclosed on March 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in CDW stock on February 24th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of EMCOR Group
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Rollins, Inc. (NYSE: ROL). In a filing disclosed on March 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Rollins stock on February 18th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of EMCOR Group
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW). In a filing disclosed on March 10th, the Representative disclosed that they had bought between $15,001 and $50,000 in C.H. Robinson Worldwide stock on February 13th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in
Representative April McClain Delaney (Democratic-Maryland) recently sold shares of The Middleby Corporation (NASDAQ: MIDD). In a filing disclosed on March 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Middleby stock on February 11th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of EMCOR
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Rollins, Inc. (NYSE: ROL). In a filing disclosed on March 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Rollins stock on February 20th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of EMCOR Group
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Rollins, Inc. (NYSE: ROL). In a filing disclosed on March 10th, the Representative disclosed that they had bought between $15,001 and $50,000 in Rollins stock on February 13th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of EMCOR Group
